Latest news
BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 09:15:18 GMTBioMarin Earnings: Voxzogo Resilience and Amicus Strength Support Positive Outlook - MorningstarMorningstar · Sat, 08 Aug 2026 05:42:25 GMTBioMarin bins rare disease asset from Inozyme acquisition - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 18:42:10 GMTBioMarin Pharmaceutical Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BMRN) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:05:22 GMTBMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:50:00 GMTBioMarin Lifts 2026 Outlook on Strong Voxzogo Sales, Wedbush Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:44:27 GMTOppenheimer Adjusts PT on BioMarin Pharmaceutical to $97 From $95, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:41:31 GMTBioMarin Pharmaceutical (BMRN) Could Be 30% Below Fair Value On Raised Guidance - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMT